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The immune systems of patients with HIV infection are
characterized by an immunodeficiency that develops in
the setting of a global immune activation and a complex
array of HIV-specific immune responses. The immunode-
ficiency of HIV infection is the result of a decrease in both
memory and naïve CD4+ T cells. Imaging studies of the
total body CD4+ T cell pool reveal global depletion
within all lymphoid tissues. Antiretroviral therapy leads
to increases in all CD4+ T cell subsets but may not fully
replete the CD4+ T cell repertoire. Expansions within the
naïve and central memory pools of CD4+ T cells can be
enhanced with the use of the T cell derived cytokine IL-2.
The clinical significance of these changes is being studied
in two phase III trials. Cytokines signalling through path-
ways similar to IL-2, namely IL-7 and IL-15, are currently
being studied as well. The mechanisms underlying the
global immune activation seen in patients with HIV infec-
tion remain to be fully elucidated. Immune activation in
patients with untreated HIV infection leads to qualitative
defects in the functions of CD8+ as well as CD4+ T cells,
elevations in IL-6 and D-dimer and is likely at least par-
tially responsible for the increased incidence of cardiovas-
cular disease recently identified as being a direct
consequence of HIV infection. The immune activation in
the CD4+ T cell subset is correlated with both the level of
CD4+ T cell depletion and the viral load while the CD8+
T cell activation is most tightly correlated to the viral load.
Efforts to block immune activation by interventions other
than antiretroviral therapy have yet to be clinically suc-
cessful. Immediately following the initiation of antiretro-
viral therapy one may see another form of immune
activation, namely the immune reconstitution inflamma-
tory syndrome. This syndrome represents an exaggerated
immune response to existing opportunistic diseases fol-
lowing the rapid improvement in immune function that
occurs with the initiation of therapy. Lowering the anti-
genic burden of opportunistic diseases prior to initiation
of antiretroviral therapy may mitigate this, at times fatal,
complication of treatment. A series of humoral and cellu-
lar immune responses have been described in patients
with HIV infection. It is not clear at present, which, if any,
of these reflect host control of HIV, and would thus be the
appropriate surrogate marker for an HIV preventive vac-
cine or a therapeutic immune based intervention.
from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9–13 November 2008
Published: 10 November 2008
Journal of the International AIDS Society 2008, 11(Suppl 1):K1 doi:10.1186/1758-2652-11-S1-K1
<supplement> <title> <p>Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1758-2652-11-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1758-2652-11-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.jiasociety.org/content/11/S1/K1
© 2008 Lane; licensee BioMed Central Ltd. 